ANI Pharmaceuticals Inc (ANIP)
65.34
+0.75
(+1.16%)
USD |
NASDAQ |
Apr 19, 15:19
ANI Pharmaceuticals Cash from Investing (Quarterly): -4.779M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.779M |
| September 30, 2023 | -4.553M |
| June 30, 2023 | -6.826M |
| March 31, 2023 | -2.353M |
| December 31, 2022 | -3.142M |
| September 30, 2022 | -9.814M |
| June 30, 2022 | -0.604M |
| March 31, 2022 | -2.178M |
| December 31, 2021 | -82.21M |
| September 30, 2021 | -0.583M |
| June 30, 2021 | -21.95M |
| March 31, 2021 | -0.737M |
| December 31, 2020 | -2.119M |
| September 30, 2020 | -5.809M |
| June 30, 2020 | -2.848M |
| March 31, 2020 | -57.55M |
| December 31, 2019 | -1.374M |
| September 30, 2019 | -1.932M |
| June 30, 2019 | -3.958M |
| March 31, 2019 | -20.28M |
| December 31, 2018 | -0.407M |
| September 30, 2018 | -18.44M |
| June 30, 2018 | -6.255M |
| March 31, 2018 | -2.278M |
| December 31, 2017 | -50.12M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.48M |
| June 30, 2017 | -2.304M |
| March 31, 2017 | -53.09M |
| December 31, 2016 | -1.389M |
| September 30, 2016 | -1.089M |
| June 30, 2016 | -61.03M |
| March 31, 2016 | -85.55M |
| December 31, 2015 | -1.105M |
| September 30, 2015 | -26.77M |
| June 30, 2015 | -0.198M |
| March 31, 2015 | -4.612M |
| December 31, 2014 | -0.338M |
| September 30, 2014 | -22.53M |
| June 30, 2014 | -0.253M |
| March 31, 2014 | -12.64M |
| December 31, 2013 | 2.231M |
| September 30, 2013 | -0.034M |
| June 30, 2013 | 19.33M |
| March 31, 2013 | -1.260M |
| December 31, 2012 | -0.0825M |
| September 30, 2012 | -0.4654M |
| June 30, 2012 | -0.0091M |
| March 31, 2012 | -0.0622M |
| December 31, 2011 | -0.0743M |
| September 30, 2011 | -0.1027M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-82.21M
Minimum
Dec 2021
-0.583M
Maximum
Sep 2021
-11.33M
Average
-3.142M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| ADMA Biologics Inc | -1.407M |
| Ligand Pharmaceuticals Inc | -10.28M |
| Dentsply Sirona Inc | -20.00M |
| Allogene Therapeutics Inc | 67.46M |
| Vanda Pharmaceuticals Inc | -43.78M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 44.74M |
| Cash from Financing (Quarterly) | -11.92M |
| Free Cash Flow | 100.45M |
| Free Cash Flow Per Share (Quarterly) | 2.070 |
| Free Cash Flow to Equity (Quarterly) | 40.17M |
| Free Cash Flow to Firm (Quarterly) | 46.97M |
| Free Cash Flow Yield | 8.44% |